Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Sanara MedTech (SMTI) Accumulated Depreciation & Amortization (2018 - 2025)

Sanara MedTech (SMTI) has disclosed Accumulated Depreciation & Amortization for 12 consecutive years, with $630467.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Accumulated Depreciation & Amortization fell 60.4% year-over-year to $630467.0, compared with a TTM value of $630467.0 through Sep 2025, down 60.4%, and an annual FY2024 reading of $608613.0, down 49.12% over the prior year.
  • Accumulated Depreciation & Amortization was $630467.0 for Q3 2025 at Sanara MedTech, up from $608613.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $1.6 million in Q3 2024 and bottomed at $342574.0 in Q4 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $826033.8, with a median of $685226.5 recorded in 2022.
  • The sharpest move saw Accumulated Depreciation & Amortization surged 174.74% in 2021, then tumbled 60.4% in 2025.
  • Year by year, Accumulated Depreciation & Amortization stood at $342574.0 in 2021, then skyrocketed by 116.01% to $739986.0 in 2022, then soared by 61.64% to $1.2 million in 2023, then crashed by 49.12% to $608613.0 in 2024, then grew by 3.59% to $630467.0 in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for SMTI at $630467.0 in Q3 2025, $608613.0 in Q4 2024, and $1.6 million in Q3 2024.